scholarly journals Chemical Characterisation of Medicinally Important Solanaceous plant Solanum xanthocarpum Schrad & Wendl

2018 ◽  
Vol 14 (01) ◽  
pp. 22-25
Author(s):  
KUMUD MODI ◽  
◽  
NEHA JATAV ◽  
Planta Medica ◽  
2014 ◽  
Vol 80 (10) ◽  
Author(s):  
RA Manek ◽  
NR Sheth ◽  
JR Chavda ◽  
JD Vaghasiya ◽  
KP Modi ◽  
...  

2014 ◽  
pp. 229-236
Author(s):  
D.A.N. Dharmasena ◽  
H.M.W.P. Herath ◽  
T. Sivananthawerl ◽  
K.B. Palipane

2014 ◽  
Vol 26 (1) ◽  
pp. 230-232
Author(s):  
B. Dheeba ◽  
P. Sampathkumar ◽  
S. Vijay ◽  
K. Kannan ◽  
M. Kannan

2011 ◽  
Vol 7 (5) ◽  
pp. 589-598 ◽  
Author(s):  
Ravi A. Manek ◽  
Navin R. Sheth ◽  
Jitendra D. Vaghasiya ◽  
Shailesh V. Malaviya ◽  
Nurudin P. Jivani ◽  
...  

2019 ◽  
Vol 16 (4) ◽  
pp. 406-416 ◽  
Author(s):  
Babatunji Emmanuel Oyinloye ◽  
Tayo Alex Adekiya ◽  
Raphael Taiwo Aruleba ◽  
Oluwafemi Adeleke Ojo ◽  
Basiru Olaitan Ajiboye

Background: In recent years, there has been an exponential increase in the global burden of cancer which has been associated with several factors including environmental influence, aging, diet, infectious agents, hormonal imbalance and chronic inflammation, among others. Cancerous cells utilize more glucose for its proliferation and survival than normal cells. Thus, the regulation of glucose consumption of cancerous cells through the inhibition of glucose transporter-4-protein (GLUT4) encoded by solute carrier family-2-member-4-gene (Slc2a4) by selected phytochemicals from Solanum xanthocarpum may serve as a new therapeutic candidate for the treatment of cancer. Methods: The seven identified potential inhibitors of GLUT4 from Solanum xanthocarpum were retrieved from PubChem database. Examination of their drug-likeness, toxicity prediction and molecular docking studies of these compounds with GLUT4 were carried out using online tools such as Molinspiration, PreADMET V.2.0 and Patchdock server. Results: The findings revealed that, five out of the seven compounds fulfil oral drugability of Lipinski’s rule of five (RO5) while two slightly meet the criteria of RO5. Conversely, five of the compounds are predicted to be mutagen while the remaining two are predicted to be safe for the body. Additionally, stigmasterol glucoside has higher binding-affinity (7590) with GLUT4 when compared to doxorubicin (6600) the control. Conclusion: These findings suggest that stigmasterol glucoside from Solanum xanthocarpum could be a promising therapeutic agent with better therapeutic efficacy than doxorubicin in the treatment of cancer via the inhibition of GLUT4.


Author(s):  
K. Subramanya Sastry ◽  
Bikash Mandal ◽  
John Hammond ◽  
S. W. Scott ◽  
R. W. Briddon
Keyword(s):  

Fitoterapia ◽  
2003 ◽  
Vol 74 (1-2) ◽  
pp. 119-121 ◽  
Author(s):  
M.T Rahman ◽  
M Ahmed ◽  
M Alimuzzaman ◽  
J.A Shilpi

2012 ◽  
Vol 2 (6) ◽  
pp. 454-460 ◽  
Author(s):  
Talib Hussain ◽  
Ramesh K Gupta ◽  
K Sweety ◽  
Mohd Sajid Khan ◽  
Md Sarfaraj Hussain ◽  
...  

Planta ◽  
1968 ◽  
Vol 81 (4) ◽  
pp. 372-375 ◽  
Author(s):  
P. S. Rao ◽  
S. Narayanaswami

Sign in / Sign up

Export Citation Format

Share Document